Search details
1.
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
Blood
; 143(13): 1231-1241, 2024 Mar 28.
Article
in English
| MEDLINE | ID: mdl-38145560
2.
Environmental oxygen affects ex vivo growth and proliferation of mesenchymal progenitors by modulating mitogen-activated protein kinase and mammalian target of rapamycin signaling.
Cytotherapy
; 24(12): 1201-1210, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36109320
3.
In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas.
Mol Ther
; 26(12): 2727-2737, 2018 12 05.
Article
in English
| MEDLINE | ID: mdl-30309819
4.
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma.
Mol Ther
; 25(9): 2214-2224, 2017 09 06.
Article
in English
| MEDLINE | ID: mdl-28602436
5.
Mesenchymal stromal cell secretomes are modulated by suspension time, delivery vehicle, passage through catheter, and exposure to adjuvants.
Cytotherapy
; 19(1): 36-46, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27856228
6.
Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.
Cytotherapy
; 19(10): 1225-1232, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28864289
7.
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.
Blood
; 122(17): 2965-73, 2013 Oct 24.
Article
in English
| MEDLINE | ID: mdl-24030379
8.
Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System.
Cytotherapy
; 16(8): 1048-58, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24726657
9.
A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 118(5): 1531-1540, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-37625523
10.
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers.
Res Sq
; 2024 Apr 03.
Article
in English
| MEDLINE | ID: mdl-38645165
11.
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.
J Clin Oncol
; : JCO2302019, 2024 May 21.
Article
in English
| MEDLINE | ID: mdl-38771986
12.
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.
Blood
; 118(23): 6050-6, 2011 Dec 01.
Article
in English
| MEDLINE | ID: mdl-21984804
13.
Manufacturing mesenchymal stromal cells for phase I clinical trials.
Cytotherapy
; 15(4): 416-22, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23480951
14.
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications.
Cytotherapy
; 14(9): 1131-43, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22900959
15.
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.
Clin Cancer Res
; 28(20): 4392-4401, 2022 10 14.
Article
in English
| MEDLINE | ID: mdl-35877117
16.
T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC.
Mol Ther Oncolytics
; 6: 69-79, 2017 Sep 15.
Article
in English
| MEDLINE | ID: mdl-28856237
17.
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
J Clin Invest
; 127(9): 3462-3471, 2017 Sep 01.
Article
in English
| MEDLINE | ID: mdl-28805662
18.
Clinical responses with T lymphocytes targeting malignancy-associated κ light chains.
J Clin Invest
; 126(7): 2588-96, 2016 07 01.
Article
in English
| MEDLINE | ID: mdl-27270177
19.
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.
J Clin Oncol
; 33(15): 1688-96, 2015 May 20.
Article
in English
| MEDLINE | ID: mdl-25800760
20.
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.
J Clin Invest
; 121(5): 1822-6, 2011 May.
Article
in English
| MEDLINE | ID: mdl-21540550